Evaluation of Phage Therapy in the Context of Enterococcus faecalis and Its Associated Diseases
- PMID: 31010053
- PMCID: PMC6521178
- DOI: 10.3390/v11040366
Evaluation of Phage Therapy in the Context of Enterococcus faecalis and Its Associated Diseases
Abstract
Bacteriophages (phages) or bacterial viruses have been proposed as natural antimicrobial agents to fight against antibiotic-resistant bacteria associated with human infections. Enterococcus faecalis is a gut commensal, which is occasionally found in the mouth and vaginal tract, and does not usually cause clinical problems. However, it can spread to other areas of the body and cause life-threatening infections, such as septicemia, endocarditis, or meningitis, in immunocompromised hosts. Although E. faecalis phage cocktails are not commercially available within the EU or USA, there is an accumulated evidence from in vitro and in vivo studies that have shown phage efficacy, which supports the idea of applying phage therapy to overcome infections associated with E. faecalis. In this review, we discuss the potency of bacteriophages in controlling E. faecalis, in both in vitro and in vivo scenarios. E. faecalis associated bacteriophages were compared at the genome level and an attempt was made to categorize phages with respect to their suitability for therapeutic application, using orthocluster analysis. In addition, E. faecalis phages have been examined for the presence of antibiotic-resistant genes, to ensure their safe use in clinical conditions. Finally, the domain architecture of E. faecalis phage-encoded endolysins are discussed.
Keywords: E. faecalis; OrthoMCL; phage therapy.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Therapeutic potential of a newly isolated bacteriophage against multi-drug resistant Enterococcus faecalis infections: in vitro and in vivo characterization.BMC Microbiol. 2025 Feb 20;25(1):80. doi: 10.1186/s12866-025-03785-z. BMC Microbiol. 2025. PMID: 39979834 Free PMC article.
-
From Isolation to Application: Utilising Phage-Antibiotic Synergy in Murine Bacteremia Model to Combat Multidrug-Resistant Enterococcus faecalis.Microb Biotechnol. 2025 Jan;18(1):e70075. doi: 10.1111/1751-7915.70075. Microb Biotechnol. 2025. PMID: 39801028 Free PMC article.
-
The Combination of Phage Therapy and β-Lactam Antibiotics for the Effective Treatment of Enterococcus faecalis Infections.Int J Mol Sci. 2024 Dec 24;26(1):11. doi: 10.3390/ijms26010011. Int J Mol Sci. 2024. PMID: 39795870 Free PMC article.
-
Phage therapy: A renewed approach against oral diseases caused by Enterococcus faecalis infections.Microb Pathog. 2024 Apr;189:106574. doi: 10.1016/j.micpath.2024.106574. Epub 2024 Feb 13. Microb Pathog. 2024. PMID: 38354990 Review.
-
Bacteriophage therapy for critical antibiotic-resistant Gram-positive bacteria: A systematic review of clinical researches.Microbiol Res. 2025 Sep;298:128231. doi: 10.1016/j.micres.2025.128231. Epub 2025 May 22. Microbiol Res. 2025. PMID: 40424685 Review.
Cited by
-
Bacteriophages to Control Multi-Drug Resistant Enterococcus faecalis Infection of Dental Root Canals.Microorganisms. 2021 Mar 3;9(3):517. doi: 10.3390/microorganisms9030517. Microorganisms. 2021. PMID: 33802385 Free PMC article.
-
Bacteriophages and Food Production: Biocontrol and Bio-Preservation Options for Food Safety.Antibiotics (Basel). 2022 Sep 28;11(10):1324. doi: 10.3390/antibiotics11101324. Antibiotics (Basel). 2022. PMID: 36289982 Free PMC article. Review.
-
Complete Genome Sequences of Two Enterococcus faecalis Bacteriophages, EFGrKN and EFGrNG, Targeted to Phage Therapy.Microbiol Resour Announc. 2021 Apr 22;10(16):e00126-21. doi: 10.1128/MRA.00126-21. Microbiol Resour Announc. 2021. PMID: 33888497 Free PMC article.
-
Enterococcus faecium Bacteriophage vB_EfaH_163, a New Member of the Herelleviridae Family, Reduces the Mortality Associated with an E. faecium vanR Clinical Isolate in a Galleria mellonella Animal Model.Viruses. 2023 Jan 7;15(1):179. doi: 10.3390/v15010179. Viruses. 2023. PMID: 36680219 Free PMC article.
-
Bacteriophage-Resistant Mutant of Enterococcus faecalis Is Impaired in Biofilm Formation.Front Microbiol. 2022 Jun 9;13:913023. doi: 10.3389/fmicb.2022.913023. eCollection 2022. Front Microbiol. 2022. PMID: 35756031 Free PMC article.
References
-
- Facklam R.R., da Carvalho M.G.S., Teixeira L.M. The Enterococci. American Society of Microbiology; Washington, DC, USA: 2002. History, Taxonomy, Biochemical Characteristics, and Antibiotic Susceptibility Testing of Enterococci; pp. 1–54.
-
- Simonsen G.S., Småbrekke L., Monnet D.L., Sørensen T.L., Møller J.K., Kristinsson K.G., Lagerqvist-Widh A., Torell E., Digranes A., Harthug S., et al. Prevalence of resistance to ampicillin, gentamicin and vancomycin in Enterococcus faecalis and Enterococcus faecium isolates from clinical specimens and use of antimicrobials in five Nordic hospitals. J. Antimicrob. Chemother. 2003;51:323–331. doi: 10.1093/jac/dkg052. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources